A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors

被引:72
作者
Andersen, NS [1 ]
Jensen, MK [1 ]
Brown, PD [1 ]
Geisler, CH [1 ]
机构
[1] Rigshosp, Dept Hematol, LYFO, Danish Lymphoma Study Grp, DK-2100 Copenhagen, Denmark
关键词
mantle cell lymphoma; population-based; incidence; clinical features; survival; prognosis;
D O I
10.1016/S0959-8049(01)00366-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study presents the first large clinical analysis of 105 unselected mantle cell lymphoma (MCL) patients diagnosed from 1992 to 2000 in a well-defined Danish population. The annual incidences were 0.7/100000 for men and 0.2/100000 for women, with no significant change during the study period. Of 97 evaluable cases, 43% achieved a complete response (CR) after initial therapy. The median disease-free (DFS) and overall survival (OS) rates were 15 and 30 months, respectively. In multivariate analysis, splenomegaly (P = 0.002), anaemia (P = 0.0001) and age (P = 0.002), but not the international prognostic index (IPI) and the Ann Arbor staging system, had an independent impact on survival. Moreover, in a sub-analysis of 45 younger MCL patients (< 65 years), a trend towards an OS plateau of 58% was observed in cases without splenomegaly and anaemia (n = 29). Thus, in contrast to previously suggested prognostic factors, these variables may prove useful for clinical decisions in a significant subset of MCL patients. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:401 / 408
页数:8
相关论文
共 24 条
[1]   Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease [J].
Andersen, NS ;
Donovan, JW ;
Borus, JS ;
Poor, CM ;
Neuberg, D ;
Aster, JC ;
Nadler, LM ;
Freedman, AS ;
Gribben, JG .
BLOOD, 1997, 90 (10) :4212-4221
[2]   Mantle cell lymphoma: A clinicopathologic study of 80 cases [J].
Argatoff, LH ;
Connors, JM ;
Klasa, RJ ;
Horsman, DE ;
Gascoyne, RD .
BLOOD, 1997, 89 (06) :2067-2078
[3]   MANTLE CELL LYMPHOMA - A PROPOSAL FOR UNIFICATION OF MORPHOLOGICAL, IMMUNOLOGICAL, AND MOLECULAR-DATA [J].
BANKS, PM ;
CHAN, J ;
CLEARY, ML ;
DELSOL, G ;
DEWOLFPEETERS, C ;
GATTER, K ;
GROGAN, TM ;
HARRIS, NL ;
ISAACSON, PG ;
JAFFE, ES ;
MASON, D ;
PILERI, S ;
RALFKIAER, E ;
STEIN, H ;
WARNKE, RA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (07) :637-640
[4]  
Beà S, 1999, BLOOD, V93, P4365
[5]   Non-Hodgkin's lymphoma subtypes over time in an unselected population of 646 patients: a study of clinico-pathological data and incidence based on a review using the REAL-classification [J].
Brincker, H ;
Pedersen, NT ;
Bendix-Hansen, K ;
Johansen, P .
LEUKEMIA & LYMPHOMA, 2000, 39 (5-6) :531-541
[6]  
Chan WC, 1997, BLOOD, V89, P3909
[7]   Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma [J].
Chiarle, R ;
Budel, LM ;
Skolnik, J ;
Frizzera, G ;
Chilosi, M ;
Corato, A ;
Pizzolo, G ;
Magidson, J ;
Montagnoli, A ;
Pagano, M ;
Maes, B ;
De Wolf-Peeters, C ;
Inghirami, G .
BLOOD, 2000, 95 (02) :619-626
[8]   Mantle cell lymphomas: Characteristics, natural history and prognostic factors of 45 cases [J].
Decaudin, D ;
Bosq, J ;
Munck, JN ;
Bayle, C ;
Koscielny, S ;
Boudjemaa, S ;
Bennaceur, A ;
Venuat, AM ;
Naccache, P ;
Bendahmane, B ;
Ribrag, V ;
Carde, P ;
Pico, JL ;
Hayat, M .
LEUKEMIA & LYMPHOMA, 1997, 26 (5-6) :539-&
[9]   Is mantle cell lymphoma a sex-related disease? [J].
Decaudin, D ;
Salanoubat, C ;
Carde, P .
LEUKEMIA & LYMPHOMA, 2000, 37 (1-2) :181-184
[10]  
FISHER RI, 1999, AM SOC HEMATOLOGY ED, P325